# Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes

> **NCT02987738** · PHASE1 · COMPLETED · sponsor: **Kinderkrankenhaus auf der Bult** · enrollment: 30 (actual)

## Conditions studied

- Type1diabetes

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT02987738
- **Lead sponsor:** Kinderkrankenhaus auf der Bult
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-09
- **Primary completion:** 2017-12-19
- **Final completion:** 2017-12-19
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02987738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02987738, "Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02987738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*